Copanlisib Pharmacodynamic Study

NCT02155582 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Hodgkin Lymphoma

Interventions

DRUG: Copanlisib (BAY80-6946)

Sponsor

Bayer